Dr. O'Dwyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-5823Fax+1 585-273-1051
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2006
Clinical Center at the National Institutes of HealthInternship, Internal Medicine, 2003 - 2004
University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
NY State Medical License 2007 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients Start of enrollment: 2014 Mar 01
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia Start of enrollment: 2019 Dec 06
Publications & Presentations
PubMed
- 323 citationsKTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 studyBijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C Logan, Nicolas Boissel
Lancet. 2021-08-07 - 21 citationsTreatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologistsKah Poh Loh, Maya Abdallah, Sindhuja Kadambi, Megan Wells, Anita J. Kumar
Leukemia & Lymphoma. 2021-01-28 - 65 citationsDiscovery of Potent Parthenolide-Based Antileukemic Agents Enabled by Late-Stage P450-Mediated C—H FunctionalizationJoshua N. Kolev, Kristen M. O'Dwyer, Craig T. Jordan, Rudi Fasan
ACS Chemical Biology. 2014-01-17
Abstracts/Posters
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...Kristen Marie O'Dwyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SWOG 1312 Final Results: A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemi...Kristen Marie O'Dwyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Combo Treatment Sans Chemotherapy Effective for Ph+ ALL ElderlyDecember 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
